Healthcare & Wellness

Allergy Skin Testing Informed Consent

Informed consent for percutaneous (prick/scratch) and/or intradermal allergy skin testing, covering the procedure, allergen panel, systemic reaction risk, pre-test medication restrictions, and post-test monitoring. Patient signer.

📄 1 signer📅 30-day expiry🏷 Healthcare & Wellness🔖 single-signer, consent, healthcare, allergy, skin-testing, prick-test, intradermal, anaphylaxis, diagnostics

About this template

The Allergy Skin Testing Informed Consent is a ready-to-use healthcare & wellness template you can send for signature in minutes. It is written for 1 signer (patient) and, by default, expires 30 days after it is sent if left unsigned. It covers consent, healthcare, allergy, skin testing, prick test, intradermal. Like every Abundera Sign template it is a convenience draft structured for ESIGN Act and UETA compliance, not a substitute for legal advice. Each signed copy is sealed with PAdES-LTA digital signatures, dual RFC 3161 timestamps, and a tamper-evident evidence package in WORM storage.

Document Preview

# Allergy Skin Testing Informed Consent > **Important — not medical advice.** For use by a licensed provider; tailor to the patient, your protocols, and state law. **Date:** ___________ **Allergy Practice / Clinic:** ___________ **Supervising Allergist / Immunologist:** ___________ **Patient Name:** ___________ **Date of Birth:** ___________ **Reason for Testing:** ___________ *E.g., perennial allergic rhinitis, seasonal allergic rhinoconjunctivitis, suspected food allergy, suspected insect venom allergy, evaluation prior to starting immunotherapy, atopic dermatitis workup* --- ## 1. Description of Allergy Skin Testing Allergy skin testing is the standard diagnostic method for identifying IgE-mediated (immediate hypersensitivity) allergic sensitivities. Results guide allergen avoidance counseling and immunotherapy extract preparation. **(a) Percutaneous (Prick / Scratch) Testing:** A small amount of standardized allergen extract is placed on the forearm or back, and the skin is pricked through the droplet with a lancet. A positive reaction produces a wheal (raised bump) and flare (surrounding redness) within 15–20 minutes, indicating the presence of allergen-specific IgE antibodies. This is the primary screening method. **(b) Intradermal Testing:** If prick testing is negative or equivocal for clinically important allergens, a small volume (0.02 mL) of diluted allergen extract is injected just beneath the skin surface with a thin needle. Intradermal testing is more sensitive but less specific than prick testing. It is NOT used for food allergens due to higher risk of systemic reaction. **(c) Panel to Be Administered Today:** **Testing Method:** ___________ **Allergen Panel:** ___________ *Describe the specific panel (e.g., Standard 65-inhalant panel including dust mites, molds, animal danders, grass/tree/weed pollens, cockroach; food panel; venom panel; drug panel).* --- ## 2. Pre-Test Medication Restrictions

Fields (13)

consent date
date · required
clinic name
text · required
allergist name
text · required
patient name
text · required
patient dob
date · required
testing reason
textarea · required
test method
select · required
allergen panel
textarea · required
meds withheld
textarea · required
med withhold confirmed
checkbox · required
hipaa ack
checkbox · required
governing state
select · required
patient signer name
text · required

Related Healthcare & Wellness templates

All 159 Healthcare & Wellness templates →  ·  Browse all templates →

Send this template with cryptographic proof

Every signed document gets PAdES-LTA digital signatures, dual RFC 3161 timestamps, and a tamper-evident evidence package sealed in WORM storage.

Try the DemoView PricingFounding Member — 50% Off